NL-OMON25556已完成不适用
Metformin and sitagliptin in patients with impaired glucose tolerance and a recent TIA or minor ischemic stroke: A multicenter, randomized, open-label phase II trial.
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 入组人数
- 100
研究概览
简要总结
/A
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •1. 18 years or older;
- •2. Clinical diagnosis of TIA, amaurosis fugax or minor ischemic stroke within the previous 6 months;
排除标准
- •1. Diabetes mellitus;
- •2. History of diabetic ketoacidosis;
研究者
相似试验
招募中
2 期
Metformin and sitagliptin in patients with impaired glucose tolerance and a recent TIA or minor ischemic stroke - safety and feasibilityimpaired glucose tolerance1001842410007963strokeNL-OMON44685Erasmus MC, Universitair Medisch Centrum Rotterdam100
进行中（未招募）
不适用
Metformin and sitagliptin in patients with impaired glucose tolerance and a recent TIA or minor ischemic stroke - a multicenter, randomized, open-label phase II trialEUCTR2011-005980-26-NL
撤回
4 期
Metformin and Sitagliptin Therapy for Adult Patients With Type 2 Diabetes Admitted to the General Medical UnitType 2 Diabetes MellitusNCT02250794Rush University Medical Center
招募中
不适用
Effects of Metformin, Sitagliptin and Empagliflozin as the first therapy for patients with type 2 diabetes: a randomized controlled study: MOSEL-first studyType2 diabetesJPRN-UMIN000035791Yokohama City University Medical Center99
已完成
2 期
Metformin and Sitagliptin in Women With Previous Gestational DiabetesPre-diabetesNCT01336322University of Pisa40